The concentrations of a,M, and in particular its stability at low pH suggest that this protein may be useful in screening for tubular abnormalities and detecting chronic asymptomatic renal tubular dysfunction.
The studies of low molecular weight proteins isolated from the urine of patients with renal tubular damage by Berggard and his colleagues have resulted in a purification of 82-microglobulin (f32M),' free light chains,2 retinol-binding protein (RBP)3 and a,-microglobulin (a,M).4 These low molecular weight proteins (<33 000 daltons) share the property of being readily filtered by the glomerulus and reabsorbed and catabolised by the proximal tubular cells.5 The measurement of urinary ,82M has been widely advocated as an indicator of tubular proteinuria, mainly as the result of the performance of this analyte as a sensitive marker of tubular damage in cadmium6 and mercury poisoning7 and more recently in following the nephrotoxic action of drugs.8 9 However, /82M loses its antigenicity at pH <6-0 and in routine clinical practice can lead to an underestimate of the intensity of low molecular weight proteinuria. Due to its stability in urine, RBP has been suggested to be used as a marker of tubular dysfunction.'0 There is considerable literature on the increased urinary excretion of enzymes of tubular origin, especially Nacetyl-B-D-glucosaminidase (NAG)'213 and alamne Accepted for publication 20 October 1982 aminopeptidase (AAP)'4 as indicators of tubular disorders especially after exposure to aminoglycosides. However, it is still uncertain which of these indicators of tubular function is most useful for routine use or whether their selection depends on the clinical condition being investigated.
It is evident that urinary a,M concentrations can be high in cadmium poisoning' and in renal failure'-'7 but so far there appears to be little information on how it relates to the spectrum of urinary analytes whose concentration can be increased in tubular disorders. a1M is a glycosylated protein of molecular weight estimated to be between 26 000 and 33 000 daltons according to the type of measurement' 18 containing 167 amino acids.'9 The liver is probably the main site of synthesis.20 Apart from severe liver disease20 when a,M can be low and in renal failure where the levels are raised'S'7 the blood concentrations of a,M undergo little change in many forms of inflammatory and neoplastic diseases." 21 25 The experimental design involved (a) examination of random urines from healthy medical students and laboratory staff, aged 19-55 yr, referred to as normal controls; (b) the screening of the urinary alM excretion in patients in whom there was considered to be an increased probability of tubular proteinuria; these included bladder cancer, paraplegia and patients with an ileal conduit following total cystectomy; (c) the use of this screen in subjects who might have tubular proteinuria, workers in the chemical industry being screened for bladder cancer and patients with rheumatic diseases and (d) detailed studies of the evolution of -acute tubular damage in burns and acute pancreatitis, and the chronic tubular damage in multiple myeloma. The latter were patients in the Medical Research Council IVth Myeloma Trial.
Only the abnormal urines as defined by an a,M > 15 mg/g creatinine were investigated in detail in the screening survey (b and c). In (d) all urines were examined in detail whatever their alM concentration.
A total of 2000 measurements of urinary a1M
were made during this investigation.
STABILITY OF aiM Seven samples of urine with a1M contents 3 mg-90 mg/l were divided into aliquots and the pH adjusted to 1-10 in steps of one pH unit. Each sample was split into two, one half stored at 4°C ovemight, and the other half at 4°C for 11 days. There was hardly any change in the urine aM concentrations of the samples stored between pH 4-0 and 10-0, below pH 4 0 there was a loss of activity of approximately 50% as the pH fell to 2-0. This indicates the a1M is stable in urine in the pathophysiological range of urine pH.
SERUM a,M CONCENTRATIONS
The relation of serum alM concentrations to serum creatinine in a hospital population (excluding patients with myelomatosis) is illustrated in Fig. 1 .
The serum values of a1M in controls, pregnancy and various diseases, but excluding patients with a serum creatinine >200 ,umoUl are shown in Table 1 .
The concentrations in bums and acute pancreatitis indicate that alM is not an acute phase reactant protein, as both these conditions are well known to provide a very powerful stimulus for the synthesis of acute phase proteins.
In multiple myeloma, in the absence of renal failure, the distribution of serum alM concentrations in patients with IgG myelomatosis was unimodal, whilst in patients with IgA myelomatosis the distribution was generally raised and showed a marked skewness with a few values >200 mg/l. These distributions are demonstrated in Table 2 .
A similar skewness in the distribution was observed in rheumatoid arthritis but was not present in the other diseases listed in Table 1 . Crossed immunoelectrophoresis, with anti-IgA in an intermediate gel showed the high concentrations aqM in the serum of patients with IgA myelomatosis were associated with the serum a1M being in two forms: a free form with an a,M electrophoretic mobility and a form bound to IgA.
URINE ANALYSIS
The normal range of urinary a,M excretion was 4-2 ± 5*6 mg/l (mean + 2 SD) (range 0-5-17 2 mg/l) or 4*2 + 6-0 mg/g (mean + 2 SD) creatinine (range 0-2-15 0 mg/g creatinine) based on 102 normal subjects. Arbitrarily, we take 15 mg/g creatinine as a normal cut-off level.
When urinary a,M was used to screen a population to assess the possibility of occult nephrotoxicity in 500 workers in the chemical industry, four cases of tubular proteinuria were detected and confirmed by their SDS-PAGE patterns (see Table 3 ).
The value of a1M in detecting unsuspected tubular proteinuria in lower urinary tract disease is illustrated by the studies of bladder cancer and paraplegic patients. In general, considering all the diseases in the study, when the urinary a,M is >15 mg/g creatinine and the ratio of a,M: total urinary protein i6 >1:30, SDS-PAGE demonstrates the presence of tubular proteinuria or a mixed glomerular and tubular pattern.
The distribution of urinary NAG activities in patients with urinary a1M >15 mg/g creatinine is illustrated in Fig. 2 analysis shown in Table 4 Urinary excretion of a,M in normal subjects has been estimated to be 9 mg/24 h4 and 5 7 mg/24 h'9 using RID and 10 mg/i'5 and 1-3 mg/24 h using an electroimmunoassay.'6 These figures reflect the different reference standards and methods used in the assays. Our assay, using the Behringwerke standard, for normal urine and serum concentrations gives similar values to those reported by Takagi et al. '9 This study has shown that the measurement of uri- 
